Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
8/10
Guangzhou KOFA Biotechnology Co., Ltd
We are professional supplier of IVD and POCT.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
8/10
Product Name: 3 In 1 (cTnI/Myo/CK-MB) Reagent Kit (Quantitative)
Method: Laternal-Flow technology (Fluorescent Immunochromatographic
Product Models: 5 tests/box, 25 tests/box, 40 tests/box, 100 tests/box
Registration NO.: 20152400171 by CFDA
Certificates: CE, ISO13485, ISO9001
Matching Equipments: Solid Phase Fluorescence Immunoassay System Manufactured by Guangzhou KOFA Biotechnology Co.,Ltd.
Introduction: This reagent kit is base on fluorescent chromatographic technology, supporting the quantitative rapid test of Myo/cTnI/CK-MB level in the serum/plasma. The combined testing of Myo/cTnI/CK-MB is used to diagnose myocardial injury and infarction.
KOFA 3 In 1 (Myo/cTnI/CK-MB Technical Parameters:
Test Item | Sample | Reacting Time | Testing Time |
3 In 1 (cTnI/Myo/CK-MB) | Plasma/Serum/Whole Blood:75μL | 15min | 3S |
The advantages of KOFA 3 In 1 (Myo/cTnI/ CK-MB):
1. Advanced fluoroimmunoassay quantitative testing platform, make accurate and quantitative rapid test of Myo/cTnI/CK-MB level available
2. Low cost and rapid test, can get the quantitative and reliable results in 15 minutes, shorten the testing turnaround time.
3. The testing results from KOFA Myo/cTnI/CK-MB has good correlation with that of Roche Diagnostics (compared with thousands of samples).
4. Simple operation and rapid test, can meet the need of various departments.
5. The combined testing of Myo, cTnI and CK-MB is more convenient, accurate and efficient than single testing items, making the patients well-treated in the shorter time.
Applicable Departments: Departments of cardiology, surgery, geriatrics, respiratory, pediatrics, obstetrics, emergency ward and ICU.